長盛軸承(300718.SZ):公開拍賣合夥企業份額被控股股東孫志華競得
格隆匯5月29日丨長盛軸承(300718.SZ)公佈,此前公司作為有限合夥人,以自有資金1億元出資成都岑宏佾企業管理服務中心,2020年12月1日,合夥企業獲得中國證券投資基金業協會私募投資基金備案證明。因公司持有的合夥企業份額可能存在減值風險,考慮到實際情況,公司以向不特定社會公眾進行公開拍賣合夥企業份額的形式處置該筆資產。公司於2023年5月22日14:00至16:00在誠拍網網絡拍賣平台上進行第三次公開拍賣,起拍價為1元,經過數輪競價,最終由買受人、公司控股股東、實際控制人、董事長孫志華以1100001元成功競得。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.